SPONSOR
University Hospital Tuebingen
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: MDDPMDDMajor Depressive DisorderCervical Intraepithelial Neoplasia Grade 2 (CIN2)Cervical Intraepithelial Neoplasia Grade 2CIN2Hematologic MalignancyCrohn DiseaseNutrition AssessmentDiet Therapy
University Hospital Tuebingen is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including MDD, PMDD, Major Depressive Disorder, Cervical Intraepithelial Neoplasia Grade 2 (CIN2).
The trial portfolio spans Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital Tuebingen
How many clinical trials has University Hospital Tuebingen sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by University Hospital Tuebingen, of which 7 are actively recruiting participants. These trials cover conditions including MDD, PMDD, Major Depressive Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital Tuebingen research focus on?
University Hospital Tuebingen clinical trials span MDD, PMDD, Major Depressive Disorder, Cervical Intraepithelial Neoplasia Grade 2 (CIN2), Cervical Intraepithelial Neoplasia Grade 2, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital Tuebingen clinical trial?
To participate in a University Hospital Tuebingen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital Tuebingen trials with current recruitment status updated daily.
Clinical Trials by University Hospital Tuebingen
NCT06130371
Recruiting
Stress, Inflammation and Neuroimaging in Major Depressive Disorder as Compared to Premenstrual Dysphoric Disorder
MDD
NCT06410599 Phase 2
Recruiting
Pharmacologic Treatment Augmentation in Chronic Depression
Major Depressive Disorder
NCT07730645
Recruiting
Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance
Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
NCT05943067 Phase 1, Phase 2
Recruiting
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Hematologic Malignancy
NCT06953791 Phase 2
Recruiting
Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Patients
Crohn Disease
NCT06156579 Phase 2
Recruiting
Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
AML
NCT03206190
Recruiting
The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4
Hereditary Spastic Paraplegia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology